ISMPP 2025-Voice of Patients, Patient Voice

“Voice of Patient” in Publications: Trends and Perspectives

This page contains a poster presented at the 21st Annual Meeting of ISMPP (International Society for Medical Publication Professionals), which took place May 12-14, 2025. Authors and affiliations Authors: Swapna Ganduri, Jeenu Jacob, Ruchika Agrawal, Nilima Vyas, Charvin D'souza, and Namita Bose Affiliation: Cactus Life Sciences, Mumbai, India Abstract Objective: Power of the patient voice can significantly improve patients’…...
Read More

Top Stories

DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Medical Review

Uncovering the Benefits of Medical Review: A Comprehensive Overview

Medical review promises scientific data accuracy and has paramount importance at all the stages of...
Periodic Safety Update Report (PSUR) - Medical Device

Periodic Safety Update Report (PSUR): A Breakdown of MDCG 2022-21

A well-structured, clear, and concise PSUR enables a seamless notified body review. Read our key...
HEOR Pharma Payers

Didactic to Dynamic: Innovative Approaches to Deeper Payer Engagements

HEOR is a fast-evolving field. Feedback from payers can influence research plans and help create...
Medical Device Regulation

Clinical Evidence: How Much Is Enough?

Ensuring the safety and functionality of your medical device is vital. But how much clinical...

From Transactional to Transformational: Bringing Patient Centricity to the Next Level

The pharma industry’s focus is shifting from the transactional approach to a transformational approach by...
Stakeholder perspectives on digital scientific content

Digital Scientific Content: Stakeholder Perspectives

What do the different relevant stakeholder groups truly expect from pharma-generated scientific content?...

Learn more ABOUT our company.